1 option
Making cures more common in kidney cancer / David McDermott.
Henry Stewart Biomedical & Life Sciences Collection Available online
Henry Stewart Biomedical & Life Sciences Collection- Format:
- Video
- Author/Creator:
- McDermott, David (Harvard Medical School, USA), Speaker.
- Series:
- Henry Stewart talks. Biomedical & life sciences collection.
- The biomedical & life sciences collection, 2056-452X
- Language:
- English
- Subjects (All):
- Kidneys--Cancer--Chemotherapy.
- Kidneys--Cancer--Immunotherapy.
- cabozantinib.
- Carcinoma, Renal Cell--drug therapy.
- Carcinoma, Renal Cell--immunology.
- Everolimus.
- Hypoxia-Inducible Factor 1.
- Immunotherapy.
- Kidney Neoplasms--drug therapy.
- Kidney Neoplasms--immunology.
- Nivolumab.
- Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors.
- relatlimab.
- Antibodies, Monoclonal, Humanized.
- Signal Transduction--drug effects.
- Translational Research, Biomedical.
- Tumor Microenvironment.
- Von Hippel-Lindau Tumor Suppressor Protein.
- Medical Subjects:
- cabozantinib.
- Carcinoma, Renal Cell--drug therapy.
- Carcinoma, Renal Cell--immunology.
- Everolimus.
- Hypoxia-Inducible Factor 1.
- Immunotherapy.
- Kidney Neoplasms--drug therapy.
- Kidney Neoplasms--immunology.
- Nivolumab.
- Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors.
- relatlimab.
- Antibodies, Monoclonal, Humanized.
- Signal Transduction--drug effects.
- Translational Research, Biomedical.
- Tumor Microenvironment.
- Von Hippel-Lindau Tumor Suppressor Protein.
- Physical Description:
- 1 videorecording (40 min., 45 sec.) : sound, color.
- Place of Publication:
- London : Henry Stewart Talks, 2023.
- System Details:
- video file
- Contents:
- Contents: Kidney cancer
- Immunotherapy in Renal-Cell Carcinoma (RCC)
- VHL/HIF/VEGF signaling pathway
- Development of therapies that generate remissions
- Patient focused objectives
- Tumor microenvironment
- Improving outcomes in advanced kidney cancer
- Novel therapies from translational research
- Cabozantinib, everolimus, nivolumab and relatlimab.
- Notes:
- Description based on publisher supplied metadata and other sources.
- Animated audio-visual presentation with synchronized narration.
- Title from title frames.
- Publisher Number:
- 6147 Henry Stewart Talks
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.